A drug used to treat colorectal cancer also can reverse a rare stomach disorder and should be considered first-line therapy for the disease, researchers report. The targeted cancer drug cetuximab, brand name Erbitux, relieved symptoms of severe Ménétrier’s disease in seven patients who completed a one-month course of treatment. Four of them showed near-complete remission, the researchers report.